When Does Using Social Media Cross The Line When It Comes To Clinical Trial Patient Confidentiality

Social media is certainly creating an altogether new category for regulatory and IRB oversight.  In this video I give my personal opinion of when utilizing tools like social media require IRB oversight.  Let me know your thoughts.